Kelvin A. Baggett, M.D., M.P.H., M.B.A.
Kelvin A. Baggett, M.D. is a Senior Managing Director in Transformation and Growth at Patient Square Capital, where he serves as the Head of Patient Impact and Chair of Patient Square’s EMPIRIC Institute. In his role as Chair of the EMPIRIC Institute, Dr. Baggett utilizes his extensive health care experience to measure and drive improvements in quality, care delivery, health outcomes, and patient impact on a large scale across Patient Square’s investments.
Dr. Baggett has held various roles in health care as a physician, clinical leader, operator, advisor, and investor. Prior to joining Patient Square, Dr. Baggett served as the Executive Vice President & Chief Impact Officer at McKesson, a Fortune 10 company. As a member of McKesson’s Executive Operating Team, he was responsible for global strategies and initiatives and played a pivotal role in shaping McKesson’s purpose of “Advancing Health Outcomes for All.”
Before McKesson, Dr. Baggett served as the Chief Operating Officer at Health Care Navigator, a Senior Vice President and the Chief Clinical Officer at Tenet Healthcare Corporation, and prior to that as the Chief Operating Officer, Clinical Services Group at HCA Healthcare. During the COVID-19 pandemic, Dr. Baggett served as a civic volunteer as the City of Dallas’ COVID-19 Health and Healthcare Access Czar.
Dr. Baggett completed his medical training in Internal Medicine at the Yale University School of Medicine. He completed advanced training as a Robert Wood Johnson Clinical Scholar at the Johns Hopkins University School of Medicine and as a Fellow at the Duke University School of Medicine. He holds an M.B.A from the Fuqua School of Business at Duke University, an M.P.H. from the Johns Hopkins Bloomberg School of Public Health, an M.D. from the Brody School of Medicine at East Carolina University, and a B.S. in Biology from the University of North Carolina at Chapel Hill.